Fluorescent Visualization in Early Oral Cancer

Not Applicable

Completed

• Conditions: Oral Squamous Cell Carcinoma or Severe Dysplasia

• Registration Number: NCT02306967
• Lead Sponsor: University of Calgary

Brief Summary

Studies from Vancouver show that fluorescent visualization (FV) is a useful method of controlling surgical margins. This early finding will now be confirmed in a national randomized controlled trial.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-09
• Study First Submitted: 2014-12-01
• Study First Submitted QC: 2014-12-01
• Study First Posted: 2014-12-03
• Primary Completion: 2017-10
• Study Completion: 2017-12
• Status Verified: 2018-05
• Last Update Submitted: 2018-05-01
• Last Update Posted: 2018-05-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• biopsy proven invasive oral cancer or severe dysplasia / Cis
• invasive cancer must be T1 or T2
• no prior history of oral cancer / treatment of oral cancer

Exclusion Criteria

• prior history of oral cancer
• unable to provide informed consent
• lesion not able to be completely visualized by FV

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
disease specific survival	5 years	disease specific 5 year survival

Trial Locations

Locations (1)

Foothills Hospital; 🇨🇦 Calgary, Alberta, Canada